XML 91 R80.htm IDEA: XBRL DOCUMENT v3.23.3
EARNINGS PER SHARE - Schedule of Earnings per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Numerator:        
Net income from continuing operations $ 386 $ 493 $ 1,202 $ 1,382
Net (income) loss attributable to noncontrolling interests (7) (6) (33) (32)
Net income from continuing operations attributable to GE HealthCare 379 487 1,169 1,350
Deemed preferred stock dividend of redeemable noncontrolling interest 0 0 (183) 0
Net income from continuing operations attributable to GE HealthCare common stockholders 379 487 986 1,350
Income (loss) from discontinued operations, net of taxes (4) 0 (4) 12
Net income attributable to GE HealthCare common stockholders $ 375 $ 487 $ 982 $ 1,362
Denominator:        
Basic weighted-average shares outstanding 455 454 455 454
Dilutive effect of common stock equivalents (in shares) 3 0 3 0
Diluted weighted-average shares outstanding 458 454 458 454
Basic Earnings Per Share:        
Continuing operations (in dollars per share) $ 0.83 $ 1.07 $ 2.17 $ 2.97
Discontinued operations (in dollars per share) (0.01) 0 (0.01) 0.03
Attributable to GE HealthCare common stockholders (in dollars per share) 0.82 1.07 2.16 3.00
Diluted Earnings Per Share:        
Continuing operations (in dollars per share) 0.83 1.07 2.16 2.97
Discontinued operations (in dollars per share) (0.01) 0 (0.01) 0.03
Attributable to GE HealthCare common stockholders (in dollars per share) $ 0.82 $ 1.07 $ 2.15 $ 3.00
Antidilutive securities (in shares) 4 0 4 0